MedTrace Logo

Clinical Trial of the Safety and Efficacy of IBA Proton Therapy System PROTEUS® PLUS (Shenzhen)

NCT07153094 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 47

Last updated 2026-01-16

No results posted yet for this study

Summary

This trial will enroll 47 subjects who will be be treated with the IBA PROTEUS® PLUS Proton Beam radiation Therapy (PBT) medical device.

The trial aims to assess the safety and efficacy of PROTEUS® PLUS for radiation therapy to oncology patients, and to provide a clinical basis for product registration application.

Conditions

  • Solid Tumor, Adult

Interventions

DEVICE

Proton Beam Therapy (PBT)

PROTEUS® PLUS

Sponsors & Collaborators

  • Ion Beam Applications

    lead INDUSTRY

Principal Investigators

  • Jing Jin, MD · Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-04
Primary Completion
2026-10-31
Completion
2031-07-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07153094 on ClinicalTrials.gov